{
    "clinical_study": {
        "@rank": "141400", 
        "acronym": "MMS-TM", 
        "arm_group": {
            "arm_group_label": "MMS test", 
            "description": "therapy monitoring of patients with colo-rectal or stomach disease or with melanoma"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is the validation of MMS test to detect active tumor growth in\n      different cancer types before and after therapy, as well as in the course of therapy and for\n      subsequent relapse control compared to standard methods (clinical examination, imaging,\n      tumor markers). It should be consider whether the MMS test has comparable diagnostic\n      accuracy, and thus can replace more expensive or invasive procedures in future."
        }, 
        "brief_title": "Validation of MMS Test for Cancer Monitoring", 
        "completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Colo-rectal Cancer", 
            "Stomach Cancer", 
            "Melanoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Rectal Neoplasms", 
                "Colorectal Neoplasms", 
                "Stomach Neoplasms", 
                "Melanoma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of colo-rectal cancer\n\n          -  Clinical diagnosis of stomach cancer\n\n          -  Suspected diagnosis of melanoma\n\n        Exclusion Criteria:\n\n          -  Colitis ulcerosa\n\n          -  Morbus Crohn\n\n          -  Cancer in time period two years before\n\n          -  Cancer therapy in time period two years before"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "patients with primary diagnosis of cancer"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02113683", 
            "org_study_id": "MMS-tm14"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "colo-rectal cancer", 
            "stomach cancer", 
            "melanoma", 
            "MMS test", 
            "therapy monitoring"
        ], 
        "lastchanged_date": "May 15, 2014", 
        "location": {
            "contact": {
                "email": "peter.reichardt@helios.kliniken.de", 
                "last_name": "Peter Reichardt, Dr. med.", 
                "phone": "+49 30 9401 548 00"
            }, 
            "facility": {
                "address": {
                    "city": "Berlin", 
                    "country": "Germany", 
                    "zip": "13125"
                }, 
                "name": "HELIOS Klinikum Berlin-Buch, Klinik f\u00fcr Interdisziplin\u00e4re Onkologie"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Validation of MMS Test to Detect Active Tumor Growth of Different Cancer Types Before and After Therapy, as Well as for Subsequent Relapse Control in Comparison to Conventional Methods", 
        "overall_contact": {
            "email": "peter.reichardt@helios-kliniken.de", 
            "last_name": "Peter Reichardt, Dr. med.", 
            "phone": "+49 30 9401 548 00"
        }, 
        "overall_official": {
            "affiliation": "MedInnovation GmbH", 
            "last_name": "Katja Waterstradt, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "active tumor growth before and after cancer therapy", 
            "safety_issue": "Yes", 
            "time_frame": "up to 36 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02113683"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "MedInnovation GmbH", 
        "sponsors": {
            "collaborator": {
                "agency": "HELIOS Klinikum Berlin-Buch", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "MedInnovation GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}